Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC Commissioners Seem POM-Skeptical In Claims Hearing

This article was originally published in The Tan Sheet

Executive Summary

“The idea that this company has built these health claims on bogus science is wrong,” says POM Wonderful counsel Edward Lazarus. But commissioners reviewing appeals of FTC’s challenge against POM’s claims for its pomegranate products appeared to believe the company made a number of implied disease claims.

You may also be interested in...



FDA And FTC Rules Indigenous To Native Advertising, Attorneys Caution

Native advertising, advertising designed to blend in with nearby non-advertising content, is becoming more popular with the growth of digital marketing. But device-makers need to be cautious about using the medium in compliance with federal promotional rules.

NAD Advises Disclosures For Native Advertising Ahead Of FTC Guidance

Ads designed to blend in with the platform where it appears can mislead consumers that the material is news content. Firms employing native advertising or sponsored content marketing should disclose their affiliation with external websites or links until FTC releases guidance, attorneys and NAD staffers say.

NAD Advises Disclosures For Native Advertising Ahead Of FTC Guidance

Ads designed to blend in with the platform where it appears can mislead consumers that the material is news content. Firms employing native advertising or sponsored content marketing should disclose their affiliation with external websites or links until FTC releases guidance, attorneys and NAD staffers say.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105944

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel